Hospira Vinorelbine Tartrate 50 mg/5 mL Injection vial

البلد: أستراليا

اللغة: الإنجليزية

المصدر: Department of Health (Therapeutic Goods Administration)

العنصر النشط:

vinorelbine tartrate, Quantity: 13.85 mg/mL

متاح من:

Hospira Australia Pty Ltd

INN (الاسم الدولي):

Vinorelbine tartrate

الشكل الصيدلاني:

Injection

تركيب:

Excipient Ingredients: water for injections

طريقة التعاطي:

Intravenous

الوحدات في الحزمة:

1 X 5 mL

الفئة:

Medicine Listed (Export Only)

نوع الوصفة الطبية :

Not scheduled. Not considered by committee

الخصائص العلاجية:

Vinorelbine is indicated as a single agent or in combination with cisplatin for the first-line treatment of ambulatory patients with unresectable, advanced nonsmall cell lung cancer (NSCLC). In patients with Stage IV NSCLC, Vinorelbine is indicated as a single agent or in combination with cisplatin. In Stage III NSCLC, Vinorelbine is indicated in combination with cisplatin.

ملخص المنتج:

Visual Identification: A clear, colourless to pale yellow solution & free from visible particulates; Container Type: Vial; Container Life Time: 2 Years; Container Temperature: Store at 2 to 8 degrees Celsius

الوضع إذن:

Licence status A

تاريخ الترخيص:

2008-05-21